Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model

Fig. 3

Observed, best fitted and counterfactual IMD case counts. Each plot reports as black points the yearly number of observed serogroup B invasive meningococcal disease (IMD) cases by age group (the first and second row report cases before and during immunization, respectively). Incidence model’s best fitted case counts are shown as blue solid lines. Red dashed lines report counterfactual IMD cases, expected in the absence of vaccination, generated through the model when setting VE to zero while leaving the other fitted parameters untouched. The blue and red semi-transparent regions are the 95% credible intervals of the corresponding expected case counts. m: age in months; y: age in years

Back to article page